Noticias de Eulerpool JCR Pharmaceuticals Co

JCR Pharmaceuticals Co Noticias de Acciones

JCR Pharmaceuticals Co es observado por muchos periodistas e inversores en todo el mundo. Aquí recopilamos las noticias más recientes de JCR Pharmaceuticals Co.

• 9 de julio ·

  Yahoo
  JCR Pharma and Alexion partner on JUST-AAV gene therapy platform
• 8 de julio ·

  Yahoo
  JCR Pharmaceuticals Enters License Agreement with Alexion for Proprietary JUST-AAV Capsids to be Used in the Development of Genomic Medicines
• 2 de julio ·

  Yahoo
  JCR Pharmaceuticals Announces the Achievement of Enrollment in the JR-141 Global Phase III Clinical Trial
• 24 de junio ·

  Yahoo
  Notice of Orphan Drug Designation for JR-446 for Mucopolysaccharidosis Type IIIB by European Commission (EC)
• 6 de junio ·

  Yahoo
  JCR Pharmaceuticals Marks 50 Years of Innovation with Launch of One-of-a-Kind Global Website
• 16 de mayo ·

  Yahoo
  JCR Pharmaceuticals Presents Preclinical Gene Therapy Data that Demonstrate Promising CNS Uptake at American Society of Gene and Cell Therapy 28th Annual Meeting
• 7 de mayo ·

  Yahoo
  Notice of Orphan Drug Designation for JR-446 for Mucopolysaccharidosis Type IIIB by the U.S. FDA
• 5 de febrero ·

  Yahoo
  JCR Pharmaceuticals’ Research Presentations at WORLDSymposium™ 2025 Showcase Research from Its Investigational Treatments for Lysosomal Storage Disorders
• 28 de enero ·

  Yahoo
  JCR Pharmaceuticals to Present at the 21st Annual WORLDSymposium™ 2025
• 6 de enero ·

  Yahoo
  JCR Pharmaceuticals and Modalis Therapeutics Announce Transition to the Next Phase of Joint Research Agreement for Development of Novel Gene Therapy